Karim Jamal, MD
Ophthalmology · Phoenix, AZNPI 1982759221
Payments from drug & device makers
Across 237 payments — averaging $424.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma Global Development$29K
- Astellas Pharma US Inc$24K
- Regeneron Healthcare Solutions, Inc.$18K
- Genentech USA, Inc.$8K
- Alimera Sciences, Inc.$6K
- Alcon$6K
- plus $10K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma Global Development | 3 | $28,994 |
| Astellas Pharma US Inc | 33 | $23,663 |
| Regeneron Healthcare Solutions, Inc. | 56 | $18,347 |
| Genentech USA, Inc. | 43 | $7,854 |
| Alimera Sciences, Inc. | 26 | $5,831 |
| Alcon | 4 | $5,727 |
| Genentech, Inc. | 4 | $5,710 |
| Regeneron | 2 | $1,505 |
| Apellis Pharmaceuticals, Inc. | 15 | $835 |
| Ocular Therapeutix, Inc. | 2 | $300 |
| Notal Vision, Inc. | 1 | $283 |
| Novartis | 10 | $278 |
| Dutch Ophthalmic, USA | 2 | $233 |
| Bausch & Lomb Americas Inc. | 10 | $210 |
| Biogen | 4 | $181 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $164 |
| Cardinal Health 110 LLC | 1 | $150 |
| AbbVie(2 entities) | 7 | $117 |
| ANI Pharmaceuticals, Inc. | 4 | $108 |
| Harrow Eye, LLC | 3 | $78 |
| Coherus Oncology, Inc. | 2 | $37 |
| Sandoz | 1 | $21 |
| Eyepoint US, Inc. | 1 | $16 |
How this compares
$100,642 in reported general payments places this provider in the 90th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Phoenix
- Ramin SchadluPhoenix$1.8M
- John CasonPhoenix$1.7M
- Benjamin HellerPhoenix$1.1M
- Neal PalejwalaPhoenix$627K
- Pravin DugelPhoenix$479K
- Robert GrossPhoenix$268K
- Sujit IttyPhoenix$216K
- Jung DaoPhoenix$213K
- Nishi ShahPhoenix$92K
- Thomas WolfPhoenix$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.